The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

The NIH has announced it will cap funds for “indirect costs” to grant recipients such as universities and hospitals.

The federal order temporarily halts the Trump administration’s plans to slash $4 billion in overhead costs for research at ...

Influenza A virus particles strategically modify their shape becoming either spheres or larger filaments to enhance their ...

NIH trial informs potential treatment strategy for kids who already tolerate half a peanut or more. 11, 2025 – Eating ...

Children with high-threshold peanut allergies showed incredible improvements after undergoing an 18-month program using store ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

National Institutes of Health (NIH) scientists and their colleagues report that a single dose of a broadly neutralizing antibody (bnAb) administered prior to virus exposure protects macaques from ...

The planned $4 billion cut for funding for scientific inquiry to the nation’s universities and academic medical institutions ...

A new study found that incrementally increasing a daily dose of peanut butter in kids with mild allergies increased their tolerance over time.

Findings suggest a safe, inexpensive, and effective pathway for allergists to treat children who already tolerate at least half a peanut.

Anthony Fauci, 84, was former President Joe Biden's chief medical adviser and a longtime director of the National Institute ...